Addex Therapeutics Statistics
Total Valuation
ADXN has a market cap or net worth of $8.01 million. The enterprise value is $4.52 million.
Important Dates
The next confirmed earnings date is Tuesday, September 30, 2025, before market open.
| Earnings Date | Sep 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ADXN has 98.35 million shares outstanding. The number of shares has increased by 17.91% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 98.35M |
| Shares Change (YoY) | +17.91% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 26.71% |
| Owned by Institutions (%) | 2.46% |
| Float | 26.11M |
Valuation Ratios
The trailing PE ratio is 0.82.
| PE Ratio | 0.82 |
| Forward PE | n/a |
| PS Ratio | 28.76 |
| Forward PS | n/a |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 0.46 |
| EV / Sales | 16.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.00.
| Current Ratio | 3.03 |
| Quick Ratio | 2.71 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -738.71 |
Financial Efficiency
Return on equity (ROE) is -163.15% and return on invested capital (ROIC) is -45.97%.
| Return on Equity (ROE) | -163.15% |
| Return on Assets (ROA) | -25.09% |
| Return on Invested Capital (ROIC) | -45.97% |
| Return on Capital Employed (ROCE) | -30.53% |
| Revenue Per Employee | $139,254 |
| Profits Per Employee | $4.90M |
| Employee Count | 2 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.15% in the last 52 weeks. The beta is 1.77, so ADXN's price volatility has been higher than the market average.
| Beta (5Y) | 1.77 |
| 52-Week Price Change | -10.15% |
| 50-Day Moving Average | 8.44 |
| 200-Day Moving Average | 8.10 |
| Relative Strength Index (RSI) | 50.41 |
| Average Volume (20 Days) | 63,798 |
Short Selling Information
| Short Interest | 45,949 |
| Short Previous Month | 1,311 |
| Short % of Shares Out | 5.20% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.80 |
Income Statement
In the last 12 months, ADXN had revenue of $278,508 and earned $9.81 million in profits. Earnings per share was $0.10.
| Revenue | 278,508 |
| Gross Profit | -587,204 |
| Operating Income | -2.91M |
| Pretax Income | -6.39M |
| Net Income | 9.81M |
| EBITDA | -2.69M |
| EBIT | -2.91M |
| Earnings Per Share (EPS) | $0.10 |
Full Income StatementBalance Sheet
The company has $3.20 million in cash and $45,480 in debt, giving a net cash position of $3.15 million or $0.03 per share.
| Cash & Cash Equivalents | 3.20M |
| Total Debt | 45,480 |
| Net Cash | 3.15M |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 9.38M |
| Book Value Per Share | 0.10 |
| Working Capital | 2.42M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.27 million and capital expenditures -$1,440, giving a free cash flow of -$4.74 million.
| Operating Cash Flow | -4.27M |
| Capital Expenditures | -1,440 |
| Free Cash Flow | -4.74M |
| FCF Per Share | -$0.05 |
Full Cash Flow StatementMargins
Gross margin is -210.84%, with operating and profit margins of -1,045.30% and 3,521.74%.
| Gross Margin | -210.84% |
| Operating Margin | -1,045.30% |
| Pretax Margin | -2,293.79% |
| Profit Margin | 3,521.74% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADXN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.91% |
| Shareholder Yield | -17.91% |
| Earnings Yield | 122.47% |
| FCF Yield | -59.13% |
Analyst Forecast
The average price target for ADXN is $30.00, which is 235.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.00 |
| Price Target Difference | 235.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on October 23, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Oct 23, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
ADXN has an Altman Z-Score of -49.11 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -49.11 |
| Piotroski F-Score | 2 |
